NCT00778232View on ClinicalTrials.gov

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Healthy
Interventions
DRUG

Gabapentin tablets 800 mg

Trial Locations (1)

58104

PRACS Institute Ltd., Fargo

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778232 - Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter